R.G.C.C. International GmbH is a leading company in analysis of circulating tumor cells as well as Cancer Stem Cells.
Through our high quality analysis at R.G.C.C. International GmbH we are able to offer a full ranges of services to the R & D, clinical, and pharmaceutical industry.
By using the most advanced and
innovative technologies of molecular and
cellular biology, R.G.C.C. International
GmbH manages to overcome some of
restrictions that are involved in the
analysis of CTCs (Circulating Tumor
Cells) and CSCs (Circulating Stem
Our thorough approach means that a massive amount of data has been generated for use in identifying new «drugable» targets.
R.G.C.C. International GmbH is offering methods in clinical practice
such as new and precise assays, risk scale and classification of cancer